{"nct_id":"NCT03152084","title":"The Study Will Evaluate Average 24-hr Sodium Excretion During Dapagliflozin Treatment in Patients With Type 2 Diabetes Mellitus With Preserved or Impaired Renal Function or Non-diabetics With Impaired Renal Function.","status":"TERMINATED","status_verified_date":"2021-05","start_date":"2017-07-12","start_date_type":"ACTUAL","primary_completion_date":"2020-03-20","primary_completion_date_type":"ACTUAL","completion_date":"2020-03-20","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["AZN"]}